PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Aclomep powder for oral solution - Acid Suppression (Children)

PAD Profile : Aclomep powder for oral solution - Acid Suppression (Children)

Keywords :
reflux, GORD, gastro-oesophageal reflux disease, indigestion, PPI, Proton pump inhibitor, gastric acid, oesophagitis, gastro-resistant, sugar free, enteral feeding tube
Brand Names Include :
Omeprazole 20mg/5ml

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
07 December 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed that unlicensed PPI oral suspensions should not be prescribed in primary care and will be given a RED traffic light status

NICU at Ashford & St Peters NHS Foundation Trust have agreed to use unlicensed omeprazole suspension (Aclomep 20mg in 5ml) in their premature babies.

This unlicensed formulation will be supplied by the trust for as long as the child needs that particular formulation.

Associated BNF Codes

01. Gastro-Intestinal System
01.03.05. Proton pump inhibitors
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More